Tag: Natco Pharma

FDA Made Six Observations to Natco Pharma’s API facility

natco
Natco Pharma announced that the US health regulator has made six observations after the completion of inspection of active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad....

New Turn in Patent Dispute Between Bristol-Myers Squibb and Natco Pharma

A patent dispute between USA-based pharma major Bristol-Myers Squibb and Indian pharma company Natco Pharma has taken a new turn with the Delhi High Court awarding interim relief to Hyderabad-based Na...

Delhi High Court Allowed Local Companies to Export Sorafenib

cancer-drugs
The Delhi High Court on Monday allowed Alembic Pharmaceuticals and Natco Pharma to export sorafenib, an active ingredient in Bayer’s cancer drug Nexavar, and rivaroxaban, the active ingredient in its ...